NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 03 04:00PM ET
6.98
Dollar change
+0.06
Percentage change
0.87
%
IndexRUT P/E- EPS (ttm)-1.24 Insider Own15.62% Shs Outstand38.80M Perf Week6.24%
Market Cap271.21M Forward P/E- EPS next Y-0.99 Insider Trans9.15% Shs Float32.79M Perf Month28.66%
Enterprise Value40.74M PEG- EPS next Q-0.43 Inst Own93.76% Short Float9.87% Perf Quarter3.87%
Income-47.87M P/S2.00 EPS this Y-59.39% Inst Trans-0.79% Short Ratio4.07 Perf Half Y-35.96%
Sales135.69M P/B0.86 EPS next Y37.68% ROA-11.81% Short Interest3.24M Perf YTD-34.34%
Book/sh8.15 P/C1.02 EPS next 5Y8.08% ROE-14.51% 52W High16.74 -58.30% Perf Year-44.95%
Cash/sh6.87 P/FCF- EPS past 3/5Y14.43% 9.19% ROIC-13.76% 52W Low4.05 72.35% Perf 3Y-59.25%
Dividend Est.- EV/EBITDA- Sales past 3/5Y7.52% 19.36% Gross Margin62.31% Volatility5.59% 8.69% Perf 5Y-74.10%
Dividend TTM- EV/Sales0.30 EPS Y/Y TTM-38.97% Oper. Margin-44.40% ATR (14)0.48 Perf 10Y-
Dividend Ex-Date- Quick Ratio7.53 Sales Y/Y TTM7.71% Profit Margin-35.28% RSI (14)64.89 Recom2.00
Dividend Gr. 3/5Y- - Current Ratio8.29 EPS Q/Q-80.87% SMA2011.90% Beta1.07 Target Price9.75
Payout- Debt/Eq0.12 Sales Q/Q-5.40% SMA5023.06% Rel Volume0.48 Prev Close6.92
Employees471 LT Debt/Eq0.10 EarningsMay 12 AMC SMA200-22.23% Avg Volume796.36K Price6.98
IPODec 07, 2017 Option/ShortYes / Yes EPS/Sales Surpr.-21.84% 7.53% Trades Volume383,527 Change0.87%
Date Action Analyst Rating Change Price Target Change
Feb-01-24Initiated Scotiabank Sector Outperform $30
Sep-25-23Upgrade Canaccord Genuity Hold → Buy $25 → $32
Aug-08-23Upgrade SVB Securities Market Perform → Outperform $30
May-23-23Upgrade Goldman Neutral → Buy $13 → $27
Aug-15-22Downgrade Canaccord Genuity Buy → Hold $40 → $12
Aug-09-22Downgrade SVB Leerink Outperform → Mkt Perform $35 → $15
Aug-09-22Downgrade Cowen Outperform → Market Perform $38 → $18
Mar-02-22Upgrade Goldman Sell → Neutral $40
Oct-15-21Resumed Cowen Outperform
Jun-04-21Initiated Goldman Sell $53
Jun-23-25 07:30AM
Jun-11-25 08:00AM
Jun-06-25 09:41AM
May-23-25 02:21PM
09:10AM
03:09AM Loading…
May-13-25 03:09AM
May-12-25 05:10PM
04:01PM
May-09-25 09:42AM
May-07-25 07:40PM
May-05-25 07:00AM
Apr-30-25 08:00AM
Apr-29-25 07:00AM
Apr-17-25 08:30AM
Apr-14-25 08:00AM
08:15AM Loading…
Apr-07-25 08:15AM
Apr-02-25 09:41AM
Apr-01-25 01:00AM
Mar-24-25 11:03AM
Mar-19-25 04:10PM
Mar-18-25 09:18AM
03:01AM
Mar-17-25 04:01PM
04:00PM
04:00PM
Mar-13-25 01:00PM
Mar-11-25 08:00AM
Mar-03-25 08:00AM
06:00AM
Feb-18-25 03:40PM
07:00AM Loading…
Jan-14-25 07:00AM
Jan-10-25 07:00AM
Jan-06-25 09:30AM
Jan-02-25 04:26PM
Dec-27-24 04:33AM
Dec-17-24 06:59AM
Nov-22-24 05:00PM
07:54AM
Nov-21-24 07:00AM
Nov-13-24 02:18AM
Nov-12-24 04:01PM
Nov-11-24 07:14AM
Nov-05-24 04:00PM
Oct-28-24 04:30PM
Oct-09-24 05:55PM
Oct-02-24 04:00PM
Sep-30-24 04:00PM
Aug-29-24 04:00PM
Aug-19-24 04:32PM
Aug-15-24 07:18PM
Aug-08-24 05:10PM
04:00PM
Aug-06-24 04:00PM
Jul-31-24 04:00PM
Jul-29-24 10:00AM
08:00AM
Jun-17-24 04:00PM
Jun-05-24 04:00PM
May-22-24 04:00PM
May-15-24 09:55AM
May-09-24 04:45PM
03:10AM
May-07-24 09:00PM
05:10PM
04:00PM
Apr-29-24 04:00PM
11:13AM
Mar-21-24 05:30PM
Mar-06-24 09:50AM
Mar-04-24 09:00AM
Mar-03-24 08:16AM
Mar-01-24 09:26AM
Feb-29-24 05:10PM
04:00PM
Feb-27-24 10:03AM
06:34AM
Feb-26-24 09:00AM
Feb-23-24 04:30PM
Feb-16-24 04:00PM
Dec-12-23 04:00PM
Dec-04-23 12:00PM
Nov-29-23 09:55AM
Nov-13-23 04:00PM
09:55AM
07:00AM
Nov-08-23 12:22PM
Nov-06-23 05:40PM
05:30PM
04:50PM
Nov-02-23 10:00AM
Oct-30-23 04:00PM
Oct-24-23 04:30PM
Oct-23-23 08:30PM
Oct-03-23 12:36PM
Sep-29-23 08:32AM
Sep-28-23 05:00PM
10:37AM
09:45AM
Sep-27-23 11:40AM
07:51AM
Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WALT DAVID RDirectorJun 13 '25Buy6.14123,990760,8031,866,933Jun 13 04:39 PM
WALT DAVID RDirectorJun 12 '25Buy6.2336,010224,1661,742,943Jun 13 04:39 PM
Toloue MasoudPresident & CEOJun 09 '25Buy5.4245,900248,723518,922Jun 10 04:08 PM
WALT DAVID RDirectorJun 06 '25Buy5.43131,869716,5761,628,802Jun 09 05:44 PM
WALT DAVID RDirectorJun 09 '25Buy5.3478,131417,2201,706,933Jun 09 05:44 PM
DONNELLY WILLIAM PDirectorJun 06 '25Buy5.4493,113506,348139,094Jun 09 05:10 PM
WALT DAVID RDirectorAug 20 '24Buy13.2947,000624,6301,487,342Sep 17 04:35 PM
Toloue MasoudPresident & CEOAug 13 '24Buy10.9019,000207,100354,119Aug 15 04:03 PM